|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Investments: | ||||||||||||||||||
| Available-for-sale securities: | ||||||||||||||||||
| Fixed maturities, at fair value (amortized cost: $25,498.7 and $23,646.5, respectively) | ||||||||||||||||||
| Marketable equity securities, at fair value (cost: $84.8 and $112.9, respectively) | ||||||||||||||||||
| Trading securities: | ||||||||||||||||||
| Marketable equity securities, at fair value (cost: $484.8 and $453.4, respectively) | ||||||||||||||||||
| Mortgage loans, net | ||||||||||||||||||
| Policy loans | ||||||||||||||||||
| Investments in limited partnerships (includes $51.5 and $71.5 at fair value, respectively) | ||||||||||||||||||
| Other invested assets (includes $101.4 and $95.8 at fair value, respectively) | ||||||||||||||||||
| Total investments | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Accrued investment income | ||||||||||||||||||
| Reinsurance recoverables | ||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||
| Receivables and other assets | ||||||||||||||||||
| Separate account assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||
| Funds held under deposit contracts | ||||||||||||||||||
| Future policy benefits | ||||||||||||||||||
| Policy and contract claims | ||||||||||||||||||
| Other policyholders' funds | ||||||||||||||||||
| Notes payable | ||||||||||||||||||
| Deferred income tax liabilities, net | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Separate account liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Preferred stock, $0.01 par value; 10,000,000 shares authorized; none issued | ||||||||||||||||||
| Common stock, $0.01 par value; 750,000,000 shares authorized; 125,207,705 issued and 116,154,402 outstanding as of September 30, 2015; 124,850,754 issued and 115,797,451 outstanding as of December 31, 2014 | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Treasury stock, at cost; 9,053,303 shares as of both September 30, 2015 and December 31, 2014 | ||||||||||||||||||
| Retained earnings | ||||||||||||||||||
| Accumulated other comprehensive income, net of taxes | ||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||
Loading...
